Oral contraceptives and myocardial infarction.

[1]  A. Walker,et al.  Mortality among oral contraceptive users , 1987, BMJ.

[2]  E. Feldman,et al.  Lipid and lipoprotein changes in women taking low‐dose, triphasic oral contraceptives: A controlled, comparative, 12‐month clinical trial , 1989, American journal of obstetrics and gynecology.

[3]  C. Shively,et al.  From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. , 1989, American journal of obstetrics and gynecology.

[4]  P. Croft,et al.  Risk factors for acute myocardial infarction in women. , 1989, BMJ.

[5]  P. Croft,et al.  Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study. , 1989, BMJ.

[6]  W. Willett,et al.  A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases , 1988 .

[7]  D. Mant,et al.  Myocardial infarction and angina pectoris in young women. , 1987, Journal of epidemiology and community health.

[8]  T. Clarkson,et al.  Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. , 1987, Fertility and sterility.

[9]  J. Goldzieher,et al.  Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. , 1985, American journal of obstetrics and gynecology.

[10]  P. Wahl,et al.  Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. , 1983, The New England journal of medicine.

[11]  P. Lichtlen,et al.  Coronary atherosclerosis and myocardial infarction in young women--role of oral contraceptives. , 1983, European heart journal.

[12]  S. Shapiro,et al.  Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. , 1981, The New England journal of medicine.

[13]  K. Macrae,et al.  Oral contraceptives and the decline in mortality from circulatory disease. , 1981, Fertility and sterility.

[14]  S. Thompson,et al.  Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. , 1980, British medical journal.

[15]  S Ramcharan,et al.  Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors. , 1979, JAMA.

[16]  N. Gregson.  Letter: Trisomy-20 syndrome in man. , 1976, Lancet.